THC Biomed Intl Ltd C.THC

Alternate Symbol(s): THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.

CSE:THC - Post by User

THC Biomed Intl Ltd > I can see edibles bigger profit margin. Cost of sales down

<< Previous

Bullboard Posts

Next >>

Comment by RamboOO7on Apr 02, 2022 9:11am

91 Views

Post# 34569783

RE:I can see edibles bigger profit margin. Cost of sales down

Q2

RamboOO7 wrote: Revenue $ 606,826$ ... Cost of sales $(436,672) Gross profit before fair value adjustments $170,154.......... i see in the past higher sales revenue but cost of sales was higher.because of dry flower. .. Conclusion if THC Sells more dry they have to sell this pot 20% THC and over at a descent price to balance revenue versus costs. I see revenue from edible versus cost of sales very good. Conclusion i see profit margins improving with edible sales improving. I guess this is called part of growing pains for a company. I will be looking forward to see edible revenues for THC Biomed from OCS in Q4.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide